ProfileGDS5678 / 1418625_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 99% 99% 99% 99% 99% 99% 99% 99% 98% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.544998
GSM967853U87-EV human glioblastoma xenograft - Control 210.931599
GSM967854U87-EV human glioblastoma xenograft - Control 311.079599
GSM967855U87-EV human glioblastoma xenograft - Control 410.937399
GSM967856U87-EV human glioblastoma xenograft - Control 511.119999
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.578799
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.690499
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.751599
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.732799
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.677298
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.806799
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.747199
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.010199
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.891499